<DOC>
	<DOCNO>NCT01590875</DOCNO>
	<brief_summary>Adenosine use clinically assess permanency electrical isolation pulmonary vein atrial fibrillation ablation , however , methodology validate either term reproducibility adenosine response effect clinical outcome , namely whether use pulmonary vein reconnection guide additional ablation lower rate recurrent atrial fibrillation post ablation . Study test hypothesis response adenosine use manner reproducible time .</brief_summary>
	<brief_title>Validation Durability Adenosine Effect Verification Pulmonary Vein Isolation</brief_title>
	<detailed_description>Patients undergo pulmonary vein isolation part atrial fibrillation ablation randomize treatment control group . Treatment group subject receive 12 mg IV adenosine evaluate pulmonary vein reconnection initial electrical isolation document . If electrical reconnection observe 5 minute , second dose adenosine administer , monitor electrical reconnection . Control patient observe 10 minute post initial electrical isolation pulmonary vein spontaneous electrical reconnection . If reconnection observe , vein re-isolated per standard clinical practice . This procedure repeat patient 's pulmonary vein . Patients follow clinical visit examine adverse effect procedure and/or adenosine administration well atrial fibrillation recurrence .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Adenosine</mesh_term>
	<criteria>Patients undergo atrial fibrillation ablation , pulmonary vein isolation catheter standard clinical indication allergy contraindication adenosine , inability give inform consent , currently take dipyridamole , verapamil theophylline breastfeed mother .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>atrial fibrillation</keyword>
	<keyword>ablation</keyword>
	<keyword>pulmonary vein</keyword>
	<keyword>adenosine</keyword>
</DOC>